An evergreen fund is a university-affiliated investment vehicle that reinvests, rather than distributes, the returns it earns from prior investments — proceeds from an exited or profitable spinout flow back into the fund’s own capital base to finance the next cohort of startups, instead of being paid out to a limited-partner group the way a conventional closed-end venture fund’s gains are. That self-sustaining structure is why a growing number of technology transfer offices have stood one up over the past few years, and why the model has drawn renewed attention in 2026 as federal research-funding volatility has made institutions more cautious about how much of their startup pipeline depends on external, non-dilutive award cycles. This guide explains how evergreen and spinout funds actually work, how they differ from the gap and proof-of-concept funds most TTOs already run, walks through the specific university programs that are verifiably structured this way, and covers the federal-funding context driving institutional interest in internal capital.
What makes a fund “evergreen”
Not every internal startup fund is evergreen. The defining feature is the capital-recycling mechanism: when a portfolio company is acquired, goes public, or otherwise returns capital or equity value, that value is directed back into the fund rather than to an external investor base or the university’s general fund. Over time, a well-performing evergreen fund can become partially or fully self-sustaining, reducing (though rarely eliminating) its dependence on fresh gifts or institutional appropriations. Three structural variants show up in practice:
- Philanthropically seeded, evergreen by policy — the fund starts as a charitable gift or endowment-style commitment, and the institution adopts a formal policy that exit proceeds are reinvested rather than returned to donors or spent elsewhere. The University of Arizona’s Wildcat Philanthropic Seed Fund follows this pattern.
- Institutionally capitalized, evergreen by design from launch — the university commits its own funds (not third-party gifts) as the initial corpus and structures the fund from the outset so that investment profits are put back into the fund. The University of Pennsylvania’s StartUP Fund follows this pattern.
- Revenue-funded, evergreen through a standing revenue allocation — rather than (or in addition to) a one-time capital commitment, the institution dedicates a fixed share of an ongoing revenue stream, most commonly net licensing/royalty income, to the fund on a continuing basis. Georgetown University’s Evergreen Gap Fund follows this pattern.
What all three share, and what distinguishes them from a plain gift-funded gap fund, is that the fund is designed to still be making awards or investments in year ten and year twenty without requiring a fresh capital injection every cycle — success recycles into the next round of support rather than the fund simply running down to zero as it disburses its original endowment.
Evergreen funds vs. gap funds vs. proof-of-concept funds vs. venture funds
These terms get used loosely and inconsistently across tech transfer offices, which causes real confusion for faculty founders comparing what is on offer. The categories are not mutually exclusive — a fund can be both a “gap fund” and “evergreen,” as Georgetown’s example shows — but they answer different questions:
- Gap fund / proof-of-concept fund describes what the money is for: bridging the “valley of death” between a research finding and a commercializable technology, typically funding prototype development, additional data generation, or de-risking experiments needed before a license or investment is realistic. See CASRAI’s Proof-of-Concept Funding dictionary entry for the underlying concept. Most gap/proof-of-concept funds make small, milestone-based, non-dilutive awards (grants) directly to faculty labs, not equity investments in a formed company.
- Evergreen fund describes how the money is replenished (see above) — it is a capitalization and sustainability model, not a statement about what stage of company it funds.
- University venture fund typically describes a vehicle that takes an equity or convertible-note position in a formed startup, in exchange for capital, and is professionally managed with investment-committee governance closer to an institutional VC fund — sometimes run entirely in-house, sometimes through an external manager investing alongside or on behalf of the university (a structure that is not itself evergreen unless explicitly designed to be).
For the fuller landscape of non-dilutive awards, licensing income, and external dilutive capital a spinout can draw on beyond internal funds, see CASRAI’s guide to Funding Options for a University Spinout.
Verified examples: university evergreen and spinout funds
The following programs are drawn from primary institutional sources — university news offices, tech transfer/innovation office pages, and official announcements. Figures and structural details below are as publicly reported at each institution’s own source; treat any fund’s total size as a point-in-time figure that can change with subsequent fundraising rounds or allocations.
University of Pennsylvania — Penn StartUP Fund
Announced in December 2025 by Penn’s Office of the Vice Provost for Research and Office of the Chief Innovation Officer (OCINO), the Penn StartUP Fund is a $10 million evergreen investment fund that makes investments of up to $250,000 in early-stage companies founded on Penn research, technology, or know-how, where at least one founder is Penn-affiliated. OCINO manages the fund, and per the university’s own announcement, profits from successful investments are returned to the fund to finance future rounds rather than distributed externally — the defining evergreen mechanism described above.
Georgetown University — Evergreen Gap Fund
Georgetown’s Office of Technology Commercialization (OTC) runs the Evergreen Gap Fund, which traces back to a Gap Fund established in 2021 through a philanthropic gift and was rebranded and restructured in 2025 to reflect a sustainable, ongoing capitalization model: per OTC’s own program pages, the university allocates a share of net licensing revenue directly to the fund on a continuing basis, in addition to philanthropic support. The fund makes proof-of-concept and prototype-development awards to Georgetown researchers and, as of its 2026 application round, added a “Catalyst Awards” category for earlier-stage concepts alongside its established Full Application track.
University of Arizona — Wildcat Philanthropic Seed Fund
Tech Launch Arizona, the university’s technology transfer office, operates the Wildcat Philanthropic Seed Fund, launched in 2023 and structured as an evergreen vehicle: contributions are treated as charitable gifts, and proceeds from successful portfolio exits are reinvested back into the fund to support future University of Arizona startups. Per the university’s own reporting, the fund entered its investment phase after reaching a substantial share of its initial fundraising target and has made its first investments in startups commercializing university-developed technology.
UC Davis and University of Chicago — related but not confirmed as evergreen
UC Davis operates multiple spinout-facing vehicles, including the Aggie Venture Accelerator (a pre-seed fund for UC Davis and UC-system spinouts) and a separately announced life-sciences-focused fund. University of Chicago’s Polsky Center has likewise launched several venture-capital-style initiatives in the tens-of-millions range in recent years, including an externally co-managed early-stage fund investing in UChicago-affiliated startups. Public announcements for both institutions describe these as spinout-financing vehicles, but — unlike the three examples above — do not describe them, in the sources reviewed for this guide, as structured on an evergreen, profit-recycling basis specifically. They are included here for completeness and as a reminder that “spinout fund” and “evergreen fund” are not interchangeable labels; confirm the actual reinvestment mechanics directly with a given office before assuming a fund is evergreen.
Why this is getting more attention in 2026
Interest in evergreen and other internally capitalized funding models has grown alongside a genuinely disrupted federal research-funding environment. NIH’s push to cap indirect cost (F&A) reimbursement at a flat 15% was permanently enjoined by federal courts and the administration ultimately did not pursue it further, but the underlying budget pressure it reflected did not disappear, and NSF has separately faced funding cuts, grant terminations, and related litigation through 2026. Universities dependent on federal award cycles for early-stage translational research — the exact stage a gap fund or evergreen fund is meant to cover — have faced tighter and less predictable non-dilutive funding, which is a direct driver of tech transfer offices and university leadership looking harder at internally controlled, non-federal capital sources that they don’t have to re-request from an agency or legislature every cycle. CASRAI covers the federal funding landscape itself in more depth in NIH funding cuts in 2026: what actually happened, NSF Funding Cuts, Grant Terminations, and the 2026 Litigation Landscape, and University Budget Cuts and Research Layoffs Continue Into Summer 2026.
An evergreen fund does not replace federal award programs like NSF’s SBIR/STTR (“America’s Seed Fund”) or NIH SBIR/STTR — those remain larger-dollar, non-dilutive sources for a spinout once it is far enough along to qualify — but it gives a TTO discretionary capital it controls end-to-end, on a timeline it sets, for the earliest and riskiest stage before a company is competitive for federal small-business funding or outside investment. See CASRAI’s ERC Proof of Concept Grant entry and the NSF SBIR/STTR guide for how those federal non-dilutive tracks compare.
How a TTO evaluates whether an evergreen model fits
Setting up an evergreen fund is a governance and capital-strategy decision, not just a fundraising one. Institutions considering the model generally have to work through:
- Seed capital source and size — philanthropic gift, institutional appropriation, or a dedicated share of licensing revenue (or some combination), sized realistically against how many spinouts the office expects to support per year and at what typical check size.
- Investment vs. grant structure — whether awards are non-dilutive grants (more like an extension of proof-of-concept funding) or take an equity/convertible-note position (closer to a true venture fund), which determines whether “reinvestment” means recycled grant dollars or recycled exit proceeds.
- Governance and conflict-of-interest controls — an investment committee structure separate from the licensing/negotiation function, disclosure requirements for faculty founders, and — where the university itself takes equity in a company founded by its own faculty — the same institutional conflict-of-interest issues covered in CASRAI’s Faculty Conflict of Interest in Startups guide.
- Realistic time horizon — exits that replenish the fund can take a decade or more from a first award, so an evergreen fund needs a capitalization plan that assumes years of net outflow before recycling meaningfully offsets new commitments.
For the broader operational context of how a TTO decides where a given technology sits on the path from disclosure to a fundable company, see CASRAI’s guides on How University Tech Transfer Offices Evaluate and Price a License, Entrepreneurial Resources for University Spinouts and Faculty Founders, and University Innovation Accelerator Programs.
Frequently asked questions
What does “evergreen” mean in a university venture fund?
It means the fund is designed to be replenished by its own returns — proceeds from successful investments or exits are reinvested into the fund rather than distributed to outside investors, a university’s general fund, or donors, so the fund can keep making awards over an indefinite horizon rather than running down to zero.
Is an evergreen fund the same as a gap fund or proof-of-concept fund?
Not necessarily. “Gap fund” and “proof-of-concept fund” describe the purpose of the money (bridging early-stage, pre-commercial research); “evergreen” describes how the fund is capitalized and replenished. A fund can be both, as with Georgetown’s Evergreen Gap Fund, or a gap fund can be a straightforward one-time endowment that is not evergreen at all.
Why are universities creating these funds now, in 2026?
Federal research funding has become less predictable — NIH’s indirect-cost-cap dispute, NSF grant terminations and related litigation, and broader budget pressure through 2026 have made institutions more interested in internally controlled capital that doesn’t depend on a federal award cycle for the earliest, highest-risk stage of spinout formation, even though federal programs like SBIR/STTR remain a major funding source once a company is further along.
Do all evergreen funds take equity in the startups they fund?
No. Some, like a straightforward evergreen gap fund, make non-dilutive milestone grants to a faculty lab rather than an equity investment in a formed company. Others, like Penn’s StartUP Fund, do take an investment position and rely on the return of that investment (not a grant repayment) to replenish the fund. Confirm the specific mechanism with the institution’s own program page before assuming either structure.
How large do university evergreen funds typically start?
Publicly reported initial commitments vary widely by institution and funding source, from single-digit-million philanthropic gifts up to the low tens of millions for institutionally capitalized funds — there is no standard size, and a fund’s initial corpus says little on its own about how many spinouts it can realistically support per year without knowing typical award/check size.
